ライフサイエンスコーパス: n

1 r androgen deprivation therapy (ADT) (86.0%, n = 308) alone or combined with radiotherapy in prostate

2 (PAS) scores (beta=0.005, SE=0.002, p=0.021, n=131) among cases in the MPIP study.

3 a (surrogates: n = 13, rho = 0.56, p < 0.05; n = 13, rho = 0.30, p = 0.317).

4 Antiemetic overuse occurred in 24.1% (n = 163451) of patients, with highest rates among those

5 this effect in four field studies (study 1: n = 870; study 2: n = 246; study 3: n = 870; study 4: n

6 ly impaired during hospitalization, and 11% (n=174) were impaired 1 month after discharge.

7 Ninety isolates (15%, n = 590) with reduced susceptibility to ciprofloxacin we

8 hite, with mean age+/-SD 62+/-11 years; 16% (n=237) were cognitively impaired during hospitalization,

9 Overall, 14.2% (n=3741) of patients were SHIFT type.

10 a three-fold, partially intermolecular [2+2+n] (n = 1 or 2) cycloaddition with substrates containing

11 ur field studies (study 1: n = 870; study 2: n = 246; study 3: n = 870; study 4: n = 141).

12 m endothelin-1 level at baseline (2000-2004; n=3538).

13 ndustrial dry-milling in two lots from 2014 (n=120) and 2015 (n=120) of non-transgenic corn and their

14 ling in two lots from 2014 (n=120) and 2015 (n=120) of non-transgenic corn and their fractions (germ,

15 study 1: n = 870; study 2: n = 246; study 3: n = 870; study 4: n = 141).

16 the number of residue pairs (5% FDR) by 33% (n = 108 to n = 144).

17 = 13) of "CF negative" (n = 152) and 19.4% (n = 13) of "CF negative" LT + STp (n = 67) expressing is

18 apy-induced nausea and vomiting risk (32.4% [n = 106795]).

19 study 2: n = 246; study 3: n = 870; study 4: n = 141).

20 l intake of eicosapentaenoic acid (EPA; 20:5 n-3) and docosahexaenoic acid (22:6 n-3) has been associ

21 99%) and good reproducibilities (RSDs13.53%, n=3) with preconcentration factors of 4 and 72 for PHE a

22 PA; 20:5 n-3) and docosahexaenoic acid (22:6 n-3) has been associated with reduced adiposity in child

23 rall rate of primary nonadherence was 31.6% (n = 788).

24 reening of ETEC isolates revealed that 8.6% (n = 13) of "CF negative" (n = 152) and 19.4% (n = 13) of

25 and men, but in patients with low CFR (<1.6, n=163), women showed a higher frequency of nonobstructiv

26 nsaturated fatty acid concentrations and n-6:n-3 PUFA ratio lower for GSPC than C.

27 h radiotherapy in prostate cancer IS (80.8%, n = 517).

28 with a negative PSMA who received SRT, 85% (n = 23/27) demonstrated a treatment response, compared w

29 high radiochemical yield and purity (>/=98%, n > 50 preparations).

30 rly AKI to receive intra-aortic MSCs (AC607; n=67) or placebo (n=68).

31 omic assay to analyze moderate-to-severe AD (n = 59) compared to psoriasis (n = 22) and healthy contr

32 Alzheimer's disease (AD; n = 164) was identified with 70% sensitivity and specifi

33 CRSsNP (n = 33), CRSwNP (n = 45), and AERD (n = 31) and control (n = 24) subjects.

34 ut amyloid-beta accumulation (normal ageing, n = 13), and neurologically normal elderly with cortical

35 loid-beta accumulation (pathological ageing, n = 15).

36 ntrol study, we assessed the outcome of all (n = 95) renal transplanted patients with pretransplant c

37 d the inclusion criteria, all cases with AN (n = 216) and 300 randomly selected individuals without A

38 fibre, total polyunsaturated, total n-3 and n-6 fatty acid contents increased linearly (p<0.05) by r

39 m was to investigate associations of n-3 and n-6 PUFA levels in colostrum and breast milk with allerg

40 Both n-6 and n-3 polyunsaturated fatty acids are associated with lowe

41 exaenoic acid] and alpha-linolenic acid) and n-6 PUFAs (linoleic acid and arachidonic acid [AA]) in b

42 onounsaturated fatty acid concentrations and n-6:n-3 PUFA ratio lower for GSPC than C.

43 ic mouthwash samples from n = 81/160 EAC and n = 25/50 ESCC cases/matched controls.

44 tation of the aorta/hypoplastic aortic arch (n=5), tetralogy of Fallot (n=1), hypoplastic right heart

45 2014, 7039 patients underwent AVR (AVR+ARE, n=1854; AVR, n=5185) at a single institution.

46 efects: transposition of the great arteries (n=7), coarctation of the aorta/hypoplastic aortic arch (

47 secondary signals at NOS1AP (n = 2), ATP1B1 (n = 2), SCN5A (n = 1), and KCNQ1 (n = 1).

48 or Interventional Trials) guideline authors (n = 16), pharmaceutical industry statisticians (n = 3),

49 atients underwent AVR (AVR+ARE, n=1854; AVR, n=5185) at a single institution.

50 rious herbal products (n = 3), azithromycin (n = 2), and 15 other medications or dietary supplements.

51 lective antagonists (i.e., RhB-(Lys-betaNphe)n-NH2; n = 4-6) are expected to become valuable tools in

52 k Development in Young Adults] and BioImage; n=1154 and 4392, respectively).

53 re at least once before their 15th birthday (n = 5882) were excluded from the study.

54 tion in a representative sample of US Black (n = 4,201), non-Hispanic White (n = 20,217) and Hispanic

55 hings were collected from patients with BOS (n = 10), stable lung transplant patients (n = 18), and h

56 Both n-6 and n-3 polyunsaturated fatty acids are associated w

57 ce using n-alkylamines (NH2R', R' = n-butyl, n-hexyl, n-octyl) (</=0.01 carboxylates nm(-2)).

58 signed to docetaxel (n = 41) or cabazitaxel (n = 22); 44.4% received prior potent androgen receptor-t

59 the same period, deaths after breast cancer (n = 134) were significantly reduced (40 deaths [0.025% p

60 rtical areas from Alzheimer's disease cases (n = 19), neurologically normal elderly without amyloid-b

61 Mock page cases (n = 16) were administered to 213 senior medical students

62 cally (n=23) and by cardiac catheterization (n=5) after primary repair (n=4) or after surgical RV rev

63 Random assignment 2:1 to CGM (n = 105) or usual care (control group; n = 53).

64 Proportions of n-3 PUFAs (very long-chain n-3 [VLC n-3; sum of eicosapentaenoic acid, docosapentae

65 ndependent population of asthmatic children (n = 30) by using a shared healthy control population (n

66 ted agents included amoxicillin/clavulanate (n = 3), temozolomide (n = 3), various herbal products (n

67 riers of another 41 neurodevelopmental CNVs (n = 484).

68 and subjective odor perception in a cohort (n=161) comprising 36 participants with CKD, 100 particip

69 ndependent planned myocardial injury cohort (n=15; P<1.33E-04, 1-way repeated measures analysis of va

70 Coma Recovery Scale-Revised indicated coma (n = 2), vegetative state (n = 3), minimally conscious st

71 astrointestinal or genitourinary conditions (n = 268; 12%), among others.

72 these incidents had respiratory conditions (n = 387; 18%), injuries (n = 289; 13%), nonspecific sign

73 wNP (n = 45), and AERD (n = 31) and control (n = 24) subjects.

74 to psoriasis (n = 22) and healthy controls (n = 18).

75 ients (n = 16) compared to healthy controls (n = 8).

76 (n = 18), and healthy aged-matched controls (n = 10).

77 ium pyrophosphate deposition disease (CPPD) (n = 15), from the Hamann-Todd collection of human skelet

78 urinary FSH values (>11.5 mIU/mg creatinine [n = 69]) did not have a significantly different predicte

79 We collected NLFs from patients with CRSsNP (n = 33), CRSwNP (n = 45), and AERD (n = 31) and control

80 from patients with CRSsNP (n = 33), CRSwNP (n = 45), and AERD (n = 31) and control (n = 24) subjects

81 A subgroup with optimal CVRFs (n = 740) was also defined as having blood pressure <120/

82 single-center continuous flow-LVAD database (n=354) was used to identify patients with chest computed

83 twice a day (n = 36) or placebo twice a day (n = 18).

84 and ascites to rifaximin 550 mg twice a day (n = 36) or placebo twice a day (n = 18).

85 ritical care units on designated study days (n = 994).

86 eak (n = 1; 2.3%), and choroidal detachment (n = 2; 4.5%).

87 Single oral dose of 10 mg of dexamethasone (n = 293) or identical placebo (n = 283).

88 nd non-conjugated polymers, e.g. poly(9,9-di-n-octylfluorene-alt-benzothiadiazole (F8BT), poly[2-meth

89 and at least 1 eye without advanced disease (n = 317).

90 were likely to experience stage IVE disease (n = 35 of 55; 64%), with bilateral involvement (n = 27 o

91 domisation because they had organic disease (n=2 in the PENFS group; n=1 in the sham group), 57 patie

92 rs (n=389), children with genomic disorders (n=31) scored significantly poorer on all measures of int

93 = 29), diffuse large B-cell lymphoma (DLBCL; n = 34), DLBCL arising from chronic lymphocytic leukemia

94 atients were randomly assigned to docetaxel (n = 41) or cabazitaxel (n = 22); 44.4% received prior po

95 ents randomised to different DAPT durations (n=10 081) to identify the effect on bleeding and ischaem

96 lesions were studied echocardiographically (n=23) and by cardiac catheterization (n=5) after primary

97 med a denser network (total number of edges, n = 173) than the distal colorectal cancer network (n =

98 stry statisticians (n = 3), journal editors (n = 9), and regulators (n = 2) (3 participants were incl

99 Extrapyramidal side effects (n = 7) emerged at a threshold concentration of 60 ng/ml,

100 oride (TBAF) is demonstrated as an efficient n-type dopant for the conjugated polymer ClBDPPV.

101 ral, and domesticated) and treated effluent (n = 233) was used to generate a fecal library to perform

102 of the deferred cases had HSV encephalitis (n = 3120).

103 uded hyphema (n = 3; 6.8%), endophthalmitis (n = 1; 2.3%), wound leak (n = 1; 2.3%), and choroidal de

104 series included nodal (n = 151), extranodal (n = 28), and primary splenic (n = 27) MCL cases.

105 we investigate an existing data set on eye (n = 625) and skin (n = 684) color from Cape Verde, an is

106 19), TREX (n = 30), and control fellow eyes (n = 39).

107 stic aortic arch (n=5), tetralogy of Fallot (n=1), hypoplastic right heart (n=1), and common arterial

108 nonspecific signs and symptoms, e.g., fever (n = 281; 13%), and gastrointestinal or genitourinary con

109 homa (MCL; n = 28), follicular lymphoma (FL; n = 29), diffuse large B-cell lymphoma (DLBCL; n = 34),

110 e conductivity of ReS2x Se2(1-x) alloys from n-type to bipolar and p-type is realized.

111 cing in prediagnostic mouthwash samples from n = 81/160 EAC and n = 25/50 ESCC cases/matched controls

112 d aromatase inhibitor (n = 36), fulvestrant (n = 21), and tamoxifen (n = 15).

113 riptomic variation; a small number of genes (n = 263) were differentially regulated according to the

114 elegans mutations in dopamine-related genes (n = 45) for changes in tau transgene-induced behavioral

115 nce treatment (n = 23) with a control group (n = 24) in a memory and a visual perceptual task.

116 ow-up, patients from the intervention group (n = 168) showed a significantly better improvement compa

117 roup (n = 5 of 7) than in the placebo group (n = 0 of 13).

118 (P = .001) in the canakinumab-treated group (n = 5 of 7) than in the placebo group (n = 0 of 13).

119 improvement compared with the waiting group (n = 147) in the following defined primary study outcomes

120 re previously treated by CTG (control group; n = 20) or CTG + LLLT (test group; n = 20).

121 CGM (n = 105) or usual care (control group; n = 53).

122 had organic disease (n=2 in the PENFS group; n=1 in the sham group), 57 patients in the PENFS group a

123 continued treatment (n=1 in the PENFS group; n=7 in the sham group) and those who were excluded after

124 ol group; n = 20) or CTG + LLLT (test group; n = 20).

125 Two groups ( n = 60) were defined depending on the type of prosthetic

126 ssigned to a 6-month interventionist-guided (n = 125) or self-guided (n = 121) weight loss program su

127 rventionist-guided (n = 125) or self-guided (n = 121) weight loss program supporting behavioral chang

128 istory of graft-versus-host disease (GVHD) ( n = 27) was associated with higher proportions of Firmic

129 Thus, SmI2(H2O)n should be able to form very weak C-H bonds.

130 e in the presence of water and THF (SmI2(H2O)n) has in recent years become a versatile and useful rea

131 ents with early onset formed hallucinations (n=21) had reduced higher visual function at baseline, co

132 A healthy control group (HC, n = 168) was composed according to age, sex, and smoking

133 cytokine profiles of 411 patients with HCC (n = 102: 32% HBV, 54% HCV, 14% non-viral) and without HC

134 BV, 54% HCV, 14% non-viral) and without HCC (n = 309: 39% HBV, 39% HCV, 22% non-viral).

135 gy of Fallot (n=1), hypoplastic right heart (n=1), and common arterial trunk (n=1).

136 n-alkylamines (NH2R', R' = n-butyl, n-hexyl, n-octyl) (</=0.01 carboxylates nm(-2)).

137 on-Hispanic White (n = 20,217) and Hispanic (n = 5,097) groups.

138 4 were each split into high-risk (MBGrp3-HR [n=65] and MBGrp4-HR [n=85]) and low-risk (MBGrp3-LR [n=5

139 o high-risk (MBGrp3-HR [n=65] and MBGrp4-HR [n=85]) and low-risk (MBGrp3-LR [n=50] and MBGrp4-LR [n=7

140 Other complications included hyphema (n = 3; 6.8%), endophthalmitis (n = 1; 2.3%), wound leak

141 ic and ancillary findings indicative of IFD (n = 116), were included.

142 SMAD3 methylation in IIS (n = 60) and in 2 replication cohorts (the Manchester Ast

143 = 61/74; 82%), intravenous immunoglobulins (n = 71/74; 96%), and plasmapheresis (n = 17/74; 23%).

144 ed in the 3 months before LVAD implantation (n=143).

145 hospholiposomes from receptor solubilized in n-dodecyl-beta-d-maltoside analogs.

146 cember 2009 and randomly assigned to the IN (n = 76) or RE (n = 77) group.

147 termediate-risk patients (2 risk indicators; n = 5,292; 30%) had a 2.2% (95% confidence interval: -0.

148 No associations between the individual n-3 PUFAs eicosapentaenoic acid, docosapentaenoic acid,

149 ssion occurred included aromatase inhibitor (n = 36), fulvestrant (n = 21), and tamoxifen (n = 15).

150 iratory conditions (n = 387; 18%), injuries (n = 289; 13%), nonspecific signs and symptoms, e.g., fev

151 olume (n = 1157) and white matter integrity (n = 1089) between depressed individuals and controls in

152 35 of 55; 64%), with bilateral involvement (n = 27 of 55; 47%), tumor masses (n = 27 of 36; 75%), an

153 n = 315) or inactivated polio vaccine (IPV) (n = 299) at 39 weeks.

154 ), ATP1B1 (n = 2), SCN5A (n = 1), and KCNQ1 (n = 1).

155 taneous administration of RG-101 at 2 mg/kg (n = 14) or 4 mg/kg (n = 14) or received a placebo (n = 2

156 on of RG-101 at 2 mg/kg (n = 14) or 4 mg/kg (n = 14) or received a placebo (n = 2/dosing group).

157 range, or when considering only young lambs (n = 164).

158 3), minimally conscious state with language (n = 4) or post-traumatic confusional state (n = 4).

159 minimally conscious state without language (n = 3), minimally conscious state with language (n = 4)

160 riants may modify the association between LC n-3 PUFA intake and CVD risk.We determined whether a PCS

161 arction (MI), modified the association of LC n-3 PUFAs with nonfatal MI risk in Costa Rican Hispanics

162 , endophthalmitis (n = 1; 2.3%), wound leak (n = 1; 2.3%), and choroidal detachment (n = 2; 4.5%).

163 d MBGrp4-HR [n=85]) and low-risk (MBGrp3-LR [n=50] and MBGrp4-LR [n=73]) subgroups.

164 nd low-risk (MBGrp3-LR [n=50] and MBGrp4-LR [n=73]) subgroups.

165 uently presented with disseminated lymphoma (n = 34 of 55; 62%), and were likely to experience stage

166 linemia (n = 4), and marginal zone lymphoma (n = 3).

167 tion; n = 7), Waldenstrom macroglobulinemia (n = 4), and marginal zone lymphoma (n = 3).

168 volvement (n = 27 of 55; 47%), tumor masses (n = 27 of 36; 75%), and involvement of the orbit (n = 32

169 subtypes included mantle cell lymphoma (MCL; n = 28), follicular lymphoma (FL; n = 29), diffuse large

170 ated at 3.0 mg/kg in patients with melanoma (n = 16) and renal cell carcinoma (RCC; n = 15).

171 gned to daily subcutaneous anakinra, 100 mg (n = 25), or placebo (n = 25) for 4 weeks and were follow

172 T and CAC (FT: normal, n=3588 [78.0%]; mild, n=432 [9.4%]; moderate, n=217 [4.7%]; severe, n=365 [7.9

173 5 [7.9%]; CAC: normal, n=1457 [34.6%]; mild, n=1340 [31.8%]; moderate, n=772 [18.3%]; severe, n=640 [

174 ding organic milk (n=10), conventional milk (n=14) and pasture milk (n=20) from winter (n=22) and sum

175 mples were analyzed, including organic milk (n=10), conventional milk (n=14) and pasture milk (n=20)

176 , conventional milk (n=14) and pasture milk (n=20) from winter (n=22) and summer (n=22).

177 subgroup of small diameter stents (</=3 mm; n = 95), specificity(82% vs. 62%), positive predictive v

178 =3588 [78.0%]; mild, n=432 [9.4%]; moderate, n=217 [4.7%]; severe, n=365 [7.9%]; CAC: normal, n=1457

179 457 [34.6%]; mild, n=1340 [31.8%]; moderate, n=772 [18.3%]; severe, n=640 [15.2%]; P<0.0001).

180 ohort included 88 eyes in 3 groups: monthly (n = 19), TREX (n = 30), and control fellow eyes (n = 39)

181 hree-fold, partially intermolecular [2+2+n] (n = 1 or 2) cycloaddition with substrates containing thr

182 otype-positive (n=72) or phenotype-negative (n=102).

183 evealed that 8.6% (n = 13) of "CF negative" (n = 152) and 19.4% (n = 13) of "CF negative" LT + STp (n

184 ) than the distal colorectal cancer network (n = 95) (P < 0.0001 in permutation tests).

185 antagonists (i.e., RhB-(Lys-betaNphe)n-NH2; n = 4-6) are expected to become valuable tools in furthe

186 Our series included nodal (n = 151), extranodal (n = 28), and primary splenic (n =

187 Compared with noncarriers (n=389), children with genomic disorders (n=31) scored si

188 ificantly higher than those in nondiabetics (n = 39: 0.83 +/- 0.92 and 1.05 +/- 0.99 in 10(8) normal

189 7 [4.7%]; severe, n=365 [7.9%]; CAC: normal, n=1457 [34.6%]; mild, n=1340 [31.8%]; moderate, n=772 [1

190 ly different between FT and CAC (FT: normal, n=3588 [78.0%]; mild, n=432 [9.4%]; moderate, n=217 [4.7

191 stinguished six secondary signals at NOS1AP (n = 2), ATP1B1 (n = 2), SCN5A (n = 1), and KCNQ1 (n = 1)

192 ample, beta-H elimination of (Phebox)Ir(OAc)(n-octyl) (2-Oc) proceeded on a time scale of minutes at

193 The aim was to investigate associations of n-3 and n-6 PUFA levels in colostrum and breast milk wit

194 catalytic activity for hydroisomerization of n-hexane, a reaction requiring hydrogenation/dehydrogena

195 Proportions of n-3 PUFAs (very long-chain n-3 [VLC n-3; sum of eicosape

196 o severe) for adults aged 60 years or older (n = 16,770) over 3 time periods in the National Health a

197 7 of 36; 75%), and involvement of the orbit (n = 32 of 55; 58%).

198 anamivir (n=209), or 75 mg oral oseltamivir (n=205) twice a day; 11 patients discontinued the study b

199 xchange of charge between the host [Co6Te8(P(n)Pr3)6][C60]3 and the intercalant TCNE.

200 igh-quality two-dimensional atomic layered p-n heterostructures are essential for high-performance in

201 e with symmetry breaking from monoclinic P21/n into orthorhombic P21212 space groups.

202 ecifically target children on their package (n = 747; from 1.9% of foods eligible under Modified-PAHO

203 s a palliative care intervention (UC + PAL) (n = 75) at a single center.

204 Patients (n = 221) had peanut sensitivity and positive double-blin

205 Materials and Methods Adult patients (n = 13 096; mean age, 42 years; age range, 15-95 years)

206 on of white adult atopic asthmatic patients (n = 12) and control subjects (n = 12).

207 icantly elevated in bladder cancer patients (n = 16) compared to healthy controls (n = 8).

208 Here, we show in mice and cancer patients (n = 70) that lung adenocarcinomas increase bone stromal

209 n CAV-positive (n=52) and CAV-free patients (n=51).

210 cohort of HIV-1 subtype C-infected patients (n = 168), together with site-directed mutagenesis, revea

211 ioral weight loss for HIV-infected patients (n = 40).

212 d plasma was collected from sepsis patients (n = 22 subjects) within 48 hours of admission to the ICU

213 In type 2 diabetes mellitus (T2DM) patients (n = 38), the levels of dG-gx-dC and dG-gx-dA in leukocyt

214 Among the patients (n = 19) whose HBsAg levels ever dropped below 10 IU/mL,

215 S (n = 10), stable lung transplant patients (n = 18), and healthy aged-matched controls (n = 10).

216 Using the DiamondTemp (DT) catheter, pigs (n = 6) underwent discrete atrial ablation in a temperatu

217 ) or 4 mg/kg (n = 14) or received a placebo (n = 2/dosing group).

218 examethasone (n = 293) or identical placebo (n = 283).

219 neous anakinra, 100 mg (n = 25), or placebo (n = 25) for 4 weeks and were followed for an additional

220 intra-aortic MSCs (AC607; n=67) or placebo (n=68).

221 (ages 4-25 years) were treated with placebo (n = 25), Viaskin Peanut 100 mug (VP100; n = 24) or Viask

222 bulins (n = 71/74; 96%), and plasmapheresis (n = 17/74; 23%).

223 y using a shared healthy control population (n = 36) and in an independent population of white adult

224 ptor profiles were compared in CAV-positive (n=52) and CAV-free patients (n=51).

225 ients were classified as phenotype-positive (n=72) or phenotype-negative (n=102).

226 ho completed the survey of current practice (n = 46), CONSORT (Consolidated Standards of Reporting Tr

227 mozolomide (n = 3), various herbal products (n = 3), azithromycin (n = 2), and 15 other medications o

228 to-severe AD (n = 59) compared to psoriasis (n = 22) and healthy controls (n = 18).

229 the surface using n-alkylamines (NH2R', R' = n-butyl, n-hexyl, n-octyl) (</=0.01 carboxylates nm(-2))

230 Forty-five individuals with documented RA (n = 15), spondyloarthropathy (n = 15), and calcium pyrop

231 After radiotherapy (n = 85), tracer sensitivity was largely PSA-independent.

232 noma (n = 16) and renal cell carcinoma (RCC; n = 15).

233 randomly assigned to the IN (n = 76) or RE (n = 77) group.

234 identified from electronic medical records (n = 830).

235 3), journal editors (n = 9), and regulators (n = 2) (3 participants were included in 2 groups each),

236 ion for significant pulmonary regurgitation (n=21).

237 We analyzed the outcome after MV repair (n=1709) and replacement (n=213) overall, by propensity s

238 catheterization (n=5) after primary repair (n=4) or after surgical RV revalvulation for significant

239 me after MV repair (n=1709) and replacement (n=213) overall, by propensity score matching, and by inv

240 dentified heavy smokers that were resistant (n = 65) or susceptible (n = 64) to emphysema with severe

241 Nonmetabolic responders (n = 6) (stable metabolic disease or progressive disease)

242 is of IFD based on reference method results (n = 117), and specimens with negative fungal culture, bu

243 tory analysis using the per-protocol sample (n = 153) failed to show noninferiority of GSH-I (adjuste

244 rs of 12 CNVs associated with schizophrenia (n = 1087) and of carriers of another 41 neurodevelopment

245 ls at NOS1AP (n = 2), ATP1B1 (n = 2), SCN5A (n = 1), and KCNQ1 (n = 1).

246 40 [31.8%]; moderate, n=772 [18.3%]; severe, n=640 [15.2%]; P<0.0001).

247 =432 [9.4%]; moderate, n=217 [4.7%]; severe, n=365 [7.9%]; CAC: normal, n=1457 [34.6%]; mild, n=1340

248 d to undergo either standard PM ("no shave", n = 116) or have additional CSM taken ("shave", n = 119)

249 116) or have additional CSM taken ("shave", n = 119).

250 existing data set on eye (n = 625) and skin (n = 684) color from Cape Verde, an island nation off Wes

251 nt set of human colorectal cancer specimens (n = 37) revealed the model recapitulated the spatial lay

252 ), extranodal (n = 28), and primary splenic (n = 27) MCL cases.

253 documented RA (n = 15), spondyloarthropathy (n = 15), and calcium pyrophosphate deposition disease (C

254 (n = 4) or post-traumatic confusional state (n = 4).

255 ed indicated coma (n = 2), vegetative state (n = 3), minimally conscious state without language (n =

256 16), pharmaceutical industry statisticians (n = 3), journal editors (n = 9), and regulators (n = 2)

257 st-line immunotherapy consisted of steroids (n = 61/74; 82%), intravenous immunoglobulins (n = 71/74;

258 nd 19.4% (n = 13) of "CF negative" LT + STp (n = 67) expressing isolates analyzed harbored CS30.

259 In 2 studies (n = 354), neck palpation was not sensitive to detect thy

260 ts (the Manchester Asthma and Allergy Study [n = 30] and the Childhood Origins of Asthma Study [n = 2

261 ] and the Childhood Origins of Asthma Study [n = 28]) was analyzed by using bisulfite sequencing or I

262 West of Scotland Coronary Prevention Study]; n=4910) and 2 observational cohort studies (CARDIA [Coro

263 atic patients (n = 12) and control subjects (n = 12).

264 e milk (n=20) from winter (n=22) and summer (n=22).

265 correlated with smartphone data (surrogates: n = 13, rho = 0.56, p < 0.05; n = 13, rho = 0.30, p = 0.

266 infants from the Southampton Women's Survey (n = 696) who were later assessed for asthma, atopic ecze

267 SC (8 surveys; n = 8413) and WRA (4 surveys; n = 4258) from the Biomarkers Reflecting the Inflammatio

268 y).Cross-sectional data for PSC (8 surveys; n = 8413) and WRA (4 surveys; n = 4258) from the Biomark

269 that were resistant (n = 65) or susceptible (n = 64) to emphysema with severe airflow obstruction in

270 restore the full 100 nucleotides of (T2AG3)n lost from replicated chromosome ends as a single elong

271 = 36), fulvestrant (n = 21), and tamoxifen (n = 15).

272 oxicillin/clavulanate (n = 3), temozolomide (n = 3), various herbal products (n = 3), azithromycin (n

273 o transcranial magnetic stimulation therapy (n = 154).

274 ere typed to CC398 and a selection of these (n = 38) were further characterised for resistance and vi

275 of residue pairs (5% FDR) by 33% (n = 108 to n = 144).

276 ants were randomly assigned to receive tOPV (n = 315) or inactivated polio vaccine (IPV) (n = 299) at

277 dietary fibre, total polyunsaturated, total n-3 and n-6 fatty acid contents increased linearly (p<0.

278 The data were divided into training (n=1625) and validation (n=637) set.

279 ymphocytic leukemia (Richter transformation; n = 7), Waldenstrom macroglobulinemia (n = 4), and margi

280 for an additional 20 weeks after treatment (n = 50).

281 sion of patients who discontinued treatment (n=1 in the PENFS group; n=7 in the sham group) and those

282 SDIs during methadone maintenance treatment (n = 23) with a control group (n = 24) in a memory and a

283 88 eyes in 3 groups: monthly (n = 19), TREX (n = 30), and control fellow eyes (n = 39).

284 There were 13 trials (n = 9850) that included kidney transplant recipients (6

285 Eighteen trials (n = 40058; range, 142-16608; mean age, 53-79 years) were

286 ight heart (n=1), and common arterial trunk (n=1).

287 2012, and June 25, 2015, to usual care (UC) (n = 75) or UC plus a palliative care intervention (UC +

288 completely displaced from the surface using n-alkylamines (NH2R', R' = n-butyl, n-hexyl, n-octyl) (<

289 vided into training (n=1625) and validation (n=637) set.

290 tions of n-3 PUFAs (very long-chain n-3 [VLC n-3; sum of eicosapentaenoic acid, docosapentaenoic acid

291 fferences in subcortical grey matter volume (n = 1157) and white matter integrity (n = 1089) between

292 a multi-ethnic cohort of healthy volunteers (n = 91) and used their tissue to generate induced plurip

293 ebo (n = 25), Viaskin Peanut 100 mug (VP100; n = 24) or Viaskin Peanut 250 mug (VP250; n = 25; DBV Te

294 0; n = 24) or Viaskin Peanut 250 mug (VP250; n = 25; DBV Technologies, Montrouge, France).

295 of US Black (n = 4,201), non-Hispanic White (n = 20,217) and Hispanic (n = 5,097) groups.

296 (n=14) and pasture milk (n=20) from winter (n=22) and summer (n=22).

297 rial from a separate group of subjects with (n = 11) or without (n = 11) COPD was collected for tissu

298 group of subjects with (n = 11) or without (n = 11) COPD was collected for tissue fibrocyte detectio

299 (61%; 95% CI, 46%-74%) compared with women (n = 660) with normal values (62%; 95% CI, 58%-66%) or af

300 Methods Eligible individuals aged 58 years (n = 1984) living in Turin, Italy, were randomly assigned

301 ncrease was among older patients (>75 years; n = 4441) who experienced an increase from 55.1 per 1000

302 ned to receive 300 mg intravenous zanamivir (n=201), 600 mg intravenous zanamivir (n=209), or 75 mg o

303 mivir (n=201), 600 mg intravenous zanamivir (n=209), or 75 mg oral oseltamivir (n=205) twice a day; 1